25 XP   0   0   10

Exagen Inc
Buy, Hold or Sell?

Let's analyse Exagen together

PenkeI guess you are interested in Exagen Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Exagen Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Exagen Inc

I send you an email if I find something interesting about Exagen Inc.

Quick analysis of Exagen (30 sec.)










What can you expect buying and holding a share of Exagen? (30 sec.)

How much money do you get?

How much money do you get?
$0.01
When do you have the money?
1 year
How often do you get paid?
18.8%

What is your share worth?

Current worth
$1.27
Expected worth in 1 year
$0.08
How sure are you?
21.9%

+ What do you gain per year?

Total Gains per Share
$-1.18
Return On Investment
-85.6%

For what price can you sell your share?

Current Price per Share
$1.38
Expected price per share
$1.3003 - $1.42
How sure are you?
50%

1. Valuation of Exagen (5 min.)




Live pricePrice per Share (EOD)

$1.38

Intrinsic Value Per Share

$21.28 - $26.27

Total Value Per Share

$22.55 - $27.54

2. Growth of Exagen (5 min.)




Is Exagen growing?

Current yearPrevious yearGrowGrow %
How rich?$22.6m$59.7m-$30.2m-102.5%

How much money is Exagen making?

Current yearPrevious yearGrowGrow %
Making money-$6m-$10.3m$4.2m70.7%
Net Profit Margin-47.6%-96.9%--

How much money comes from the company's main activities?

3. Financial Health of Exagen (5 min.)




4. Comparing to competitors in the Diagnostics & Research industry (5 min.)




  Industry Rankings (Diagnostics & Research)  


Richest
#97 / 145

Most Revenue
#96 / 145

Most Profit
#95 / 145

What can you expect buying and holding a share of Exagen? (5 min.)

Welcome investor! Exagen's management wants to use your money to grow the business. In return you get a share of Exagen.

What can you expect buying and holding a share of Exagen?

First you should know what it really means to hold a share of Exagen. And how you can make/lose money.

Speculation

The Price per Share of Exagen is $1.38. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Exagen.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Exagen, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $1.27. Based on the TTM, the Book Value Change Per Share is $-0.30 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.62 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Exagen.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.31-22.6%-0.34-24.3%-0.67-48.4%-0.43-31.1%-0.36-26.4%
Usd Book Value Change Per Share-0.28-20.4%-0.30-21.6%-0.62-44.6%0.086.0%0.042.8%
Usd Dividend Per Share0.000.0%0.000.2%0.000.2%0.021.5%0.011.0%
Usd Total Gains Per Share-0.28-20.4%-0.30-21.4%-0.61-44.5%0.107.6%0.053.8%
Usd Price Per Share1.99-2.44-4.72-8.98-5.61-
Price to Earnings Ratio-1.59--1.88--1.85--7.20--4.50-
Price-to-Total Gains Ratio-7.05--8.65--8.25--19.34--19.34-
Price to Book Ratio1.56-1.48-1.29-2.68-1.68-
Price-to-Total Gains Ratio-7.05--8.65--8.25--19.34--19.34-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.38
Number of shares724
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.02
Usd Book Value Change Per Share-0.300.08
Usd Total Gains Per Share-0.300.10
Gains per Quarter (724 shares)-213.7475.48
Gains per Year (724 shares)-854.97301.93
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
17-862-86561241292
215-1725-1720122482594
322-2587-2575183722896
430-3449-34302449631198
537-4312-428530612041500
644-5174-514036714451802
752-6037-599542816862104
859-6899-685048919262406
967-7761-770555021672708
1074-8624-856061124083010

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.020.00.00.0%0.032.00.00.0%0.036.00.00.0%
Book Value Change Per Share0.04.00.00.0%1.011.00.08.3%3.017.00.015.0%6.024.02.018.8%7.024.05.019.4%
Dividend per Share1.00.03.025.0%4.00.08.033.3%6.00.014.030.0%6.00.026.018.8%6.00.030.016.7%
Total Gains per Share0.04.00.00.0%1.011.00.08.3%4.016.00.020.0%7.023.02.021.9%8.023.05.022.2%

Fundamentals of Exagen

About Exagen Inc

Exagen Inc. develops and commercializes various testing products under the AVISE brand in the United States. The company enables healthcare providers to care for patients through the diagnosis, prognosis, and monitoring of autoimmune and autoimmune-related diseases, including systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). Its lead testing product is AVISE CTD that enables differential diagnosis for patients presenting with symptoms indicative of various connective tissue diseases (CTDs) and other related diseases with overlapping symptoms. The company offers AVISE Lupus that measures activation of the complement system by quantifying the level of B-cell C4d and erythrocyte bound C4d in the patient's blood; and AVISE APS, which consists of a panel of autoantibody tests that aids in the diagnosis and management of APS. In addition, it provides AVISE Vasculitis AAV, which utilizes a testing panel of individual analytes to provide physicians with results in the assessment and monitoring of anti-neutrophil cytoplasmic antibody associated vasculitis; AVISE SLE Prognostic, a panel of autoantibodies for assessing the potential for complications affecting the kidney, brain, and cardiovascular system; and AVISE Anti-CarP test, which identifies RA patients with severe disease. Further, the company offers AVISE SLE Monitor, a biomarker blood test; AVISE MTX, a patented and validated blood test; and AVISE HCQ, a blood test to monitor levels of hydroxychloroquine. It has a research collaboration and license agreement with Allegheny Health Network (AHN) Research Institute to develop novel patented biomarkers. The company was formerly known as Exagen Diagnostics, Inc. and changed its name to Exagen Inc. in January 2019. Exagen Inc. was incorporated in 2002 and is headquartered in Vista, California.

Fundamental data was last updated by Penke on 2024-04-12 22:42:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Exagen Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Exagen earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Exagen to the Diagnostics & Research industry mean.
  • A Net Profit Margin of -40.5% means that $-0.40 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Exagen Inc:

  • The MRQ is -40.5%. The company is making a huge loss. -2
  • The TTM is -47.6%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-40.5%TTM-47.6%+7.1%
TTM-47.6%YOY-96.9%+49.3%
TTM-47.6%5Y-54.2%+6.6%
5Y-54.2%10Y-71.9%+17.7%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-40.5%-7.7%-32.8%
TTM-47.6%-6.7%-40.9%
YOY-96.9%2.4%-99.3%
5Y-54.2%-1.5%-52.7%
10Y-71.9%-3.4%-68.5%
1.1.2. Return on Assets

Shows how efficient Exagen is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Exagen to the Diagnostics & Research industry mean.
  • -9.8% Return on Assets means that Exagen generated $-0.10 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Exagen Inc:

  • The MRQ is -9.8%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -9.2%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-9.8%TTM-9.2%-0.5%
TTM-9.2%YOY-10.2%+1.0%
TTM-9.2%5Y-7.2%-2.1%
5Y-7.2%10Y-13.5%+6.3%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-9.8%-1.7%-8.1%
TTM-9.2%-1.3%-7.9%
YOY-10.2%-0.9%-9.3%
5Y-7.2%-0.5%-6.7%
10Y-13.5%-0.9%-12.6%
1.1.3. Return on Equity

Shows how efficient Exagen is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Exagen to the Diagnostics & Research industry mean.
  • -24.6% Return on Equity means Exagen generated $-0.25 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Exagen Inc:

  • The MRQ is -24.6%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -20.8%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-24.6%TTM-20.8%-3.8%
TTM-20.8%YOY-18.5%-2.3%
TTM-20.8%5Y-11.7%-9.1%
5Y-11.7%10Y-75.1%+63.4%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-24.6%-0.7%-23.9%
TTM-20.8%-0.1%-20.7%
YOY-18.5%0.3%-18.8%
5Y-11.7%-1.4%-10.3%
10Y-75.1%-2.3%-72.8%

1.2. Operating Efficiency of Exagen Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Exagen is operating .

  • Measures how much profit Exagen makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Exagen to the Diagnostics & Research industry mean.
  • An Operating Margin of -37.4% means the company generated $-0.37  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Exagen Inc:

  • The MRQ is -37.4%. The company is operating very inefficient. -2
  • The TTM is -45.8%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-37.4%TTM-45.8%+8.4%
TTM-45.8%YOY-89.5%+43.7%
TTM-45.8%5Y-48.4%+2.6%
5Y-48.4%10Y-54.9%+6.4%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-37.4%-6.2%-31.2%
TTM-45.8%0.5%-46.3%
YOY-89.5%4.3%-93.8%
5Y-48.4%3.7%-52.1%
10Y-54.9%-1.3%-53.6%
1.2.2. Operating Ratio

Measures how efficient Exagen is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Diagnostics & Research industry mean).
  • An Operation Ratio of 1.37 means that the operating costs are $1.37 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Exagen Inc:

  • The MRQ is 1.374. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.446. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.374TTM1.446-0.072
TTM1.446YOY1.895-0.449
TTM1.4465Y1.489-0.043
5Y1.48910Y1.557-0.068
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ1.3741.296+0.078
TTM1.4461.301+0.145
YOY1.8951.238+0.657
5Y1.4891.268+0.221
10Y1.5571.217+0.340

1.3. Liquidity of Exagen Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Exagen is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Diagnostics & Research industry mean).
  • A Current Ratio of 4.02 means the company has $4.02 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Exagen Inc:

  • The MRQ is 4.020. The company is very able to pay all its short-term debts. +2
  • The TTM is 5.476. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ4.020TTM5.476-1.456
TTM5.476YOY8.202-2.726
TTM5.4765Y9.288-3.813
5Y9.28810Y6.017+3.271
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ4.0202.111+1.909
TTM5.4762.298+3.178
YOY8.2022.581+5.621
5Y9.2883.012+6.276
10Y6.0173.081+2.936
1.3.2. Quick Ratio

Measures if Exagen is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Exagen to the Diagnostics & Research industry mean.
  • A Quick Ratio of 3.62 means the company can pay off $3.62 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Exagen Inc:

  • The MRQ is 3.617. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 5.073. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ3.617TTM5.073-1.456
TTM5.073YOY7.892-2.819
TTM5.0735Y8.924-3.851
5Y8.92410Y5.722+3.202
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ3.6171.204+2.413
TTM5.0731.285+3.788
YOY7.8921.565+6.327
5Y8.9241.925+6.999
10Y5.7222.128+3.594

1.4. Solvency of Exagen Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Exagen assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Exagen to Diagnostics & Research industry mean.
  • A Debt to Asset Ratio of 0.60 means that Exagen assets are financed with 60.1% credit (debt) and the remaining percentage (100% - 60.1%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Exagen Inc:

  • The MRQ is 0.601. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.550. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.601TTM0.550+0.052
TTM0.550YOY0.434+0.116
TTM0.5505Y0.478+0.072
5Y0.47810Y0.987-0.509
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6010.421+0.180
TTM0.5500.407+0.143
YOY0.4340.394+0.040
5Y0.4780.448+0.030
10Y0.9870.446+0.541
1.4.2. Debt to Equity Ratio

Measures if Exagen is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Exagen to the Diagnostics & Research industry mean.
  • A Debt to Equity ratio of 150.9% means that company has $1.51 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Exagen Inc:

  • The MRQ is 1.509. The company is just able to pay all its debts with equity.
  • The TTM is 1.235. The company is able to pay all its debts with equity. +1
Trends
Current periodCompared to+/- 
MRQ1.509TTM1.235+0.274
TTM1.235YOY0.780+0.455
TTM1.2355Y0.693+0.542
5Y0.69310Y5.534-4.841
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ1.5090.606+0.903
TTM1.2350.567+0.668
YOY0.7800.631+0.149
5Y0.6930.658+0.035
10Y5.5340.742+4.792

2. Market Valuation of Exagen Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Exagen generates.

  • Above 15 is considered overpriced but always compare Exagen to the Diagnostics & Research industry mean.
  • A PE ratio of -1.59 means the investor is paying $-1.59 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Exagen Inc:

  • The EOD is -1.104. Based on the earnings, the company is expensive. -2
  • The MRQ is -1.592. Based on the earnings, the company is expensive. -2
  • The TTM is -1.877. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.104MRQ-1.592+0.488
MRQ-1.592TTM-1.877+0.285
TTM-1.877YOY-1.847-0.029
TTM-1.8775Y-7.199+5.322
5Y-7.19910Y-4.499-2.699
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD-1.104-0.261-0.843
MRQ-1.592-0.409-1.183
TTM-1.877-0.341-1.536
YOY-1.8470.002-1.849
5Y-7.1994.832-12.031
10Y-4.4995.198-9.697
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Exagen Inc:

  • The EOD is 0.747. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 1.076. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is -1.218. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD0.747MRQ1.076-0.330
MRQ1.076TTM-1.218+2.295
TTM-1.218YOY-2.175+0.956
TTM-1.2185Y-9.666+8.448
5Y-9.66610Y-6.042-3.625
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD0.747-0.291+1.038
MRQ1.076-0.441+1.517
TTM-1.218-1.388+0.170
YOY-2.175-2.079-0.096
5Y-9.666-1.446-8.220
10Y-6.042-1.971-4.071
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Exagen is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Diagnostics & Research industry mean).
  • A PB ratio of 1.56 means the investor is paying $1.56 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Exagen Inc:

  • The EOD is 1.085. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.564. Based on the equity, the company is underpriced. +1
  • The TTM is 1.478. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.085MRQ1.564-0.479
MRQ1.564TTM1.478+0.086
TTM1.478YOY1.291+0.187
TTM1.4785Y2.682-1.204
5Y2.68210Y1.676+1.006
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD1.0851.857-0.772
MRQ1.5642.228-0.664
TTM1.4782.222-0.744
YOY1.2913.104-1.813
5Y2.6823.447-0.765
10Y1.6764.036-2.360
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Exagen Inc.

3.1. Institutions holding Exagen Inc

Institutions are holding 59.609% of the shares of Exagen Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31RTW INVESTMENTS, LLC8.82680.04681504602121700.8154
2023-12-31COWEN AND COMPANY, LLC5.27180.1173898630562546.678
2023-12-31Wasatch Advisors Inc.4.98840.0093850308-5965-0.6966
2023-12-31Stonepine Capital Management Llc3.92870.5763669684-533807-44.3549
2023-12-31Silvercrest Asset Management Group LLC3.19650.007754487700
2023-12-31Perkins Capital Management Inc2.98550.865250890524500092.8364
2023-12-31Vanguard Group Inc2.8801049094400
2023-12-31Morgan Stanley - Brokerage Accounts2.83890.000148392029200.6071
2023-12-31Nantahala Capital Management, LLC1.13960.01161942488747981.933
2023-12-31Geode Capital Management, LLC0.478608158300
2023-12-31Penbrook Management LLC0.44420.10127571023003.1331
2023-12-31UBS Group AG0.3661062409-68424-52.2987
2023-12-31BlackRock Inc0.3393057835-9235-13.7692
2023-12-31Renaissance Technologies Corp0.26690.000145488454880
2023-12-31Bridgeway Capital Management, LLC0.23940.00174080000
2023-12-31Dimensional Fund Advisors, Inc.0.2114036030-18369-33.7672
2023-12-31State Street Corporation0.197603369100
2023-12-31Millennium Management LLC0.1385023615-7606-24.3618
2023-12-31Northern Trust Corp0.096401644000
2023-12-31First Bank & Trust (Brookings SD)0.07930.006513518-857-5.9617
Total 38.9141.74386633237-192652-2.9%

3.2. Funds holding Exagen Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31Wasatch Ultra Growth4.68770.1342807953-6083-0.7473
2024-02-29Vanguard Total Stock Mkt Idx Inv1.8930.000132626600
2023-12-31Silvercrest U.S. Small Cap Growth0.88850.154715314300
2024-02-29Vanguard Institutional Extnd Mkt Idx Tr0.82360.000314195100
2024-02-29Fidelity Extended Market Index0.26450.000345596-221-0.4824
2023-12-31Bridgeway Ultra-Small Company Market0.22630.04183900000
2024-03-28iShares Micro-Cap ETF0.12130.00362090900
2023-12-31Perkins Discovery0.09570.43061650000
2024-02-29Fidelity Series Total Market Index0.063601096200
2024-02-29Fidelity Total Market Index0.058201003900
2024-02-29Vanguard Instl Ttl Stk Mkt Idx InstlPls0.05750.0001991900
2023-10-31Vanguard Instl Ttl Stck Mkt Idx Tr0.05750.00019919-316347-96.9598
2024-02-29Vanguard Balanced Index Inv0.05030866700
2024-02-29Fidelity Nasdaq Composite Index0.04950.0001853300
2023-12-31NT Ext Equity Mkt Idx Fd - NL0.04650.0003800700
2024-02-29DFA US Core Equity 2 I0.04530.0001780000
2023-12-31NT Ext Equity Mkt Idx Fd - L0.04220.0003726600
2023-12-31Northern Trust Extended Eq Market Idx0.04220.0003726600
2024-02-29DFA US Vector Equity I0.04170.0003718700
2023-12-31NT Ext Equity Mkt Idx Fd - DC - NL - T20.03730.00036431120.1869
Total 9.59240.76751653314-322639-19.5%

3.3. Insider Transactions

Insiders are holding 30.423% of the shares of Exagen Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2024-03-04Kamal AdawiSELL127841.91
2023-10-17John AballiSELL338191.75
2023-06-15James L L TullisBUY1673.11

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Exagen Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.282-0.298+6%-0.616+118%0.083-439%0.039-825%
Book Value Per Share--1.2721.671-24%3.466-63%2.975-57%1.569-19%
Current Ratio--4.0205.476-27%8.202-51%9.288-57%6.017-33%
Debt To Asset Ratio--0.6010.550+9%0.434+39%0.478+26%0.987-39%
Debt To Equity Ratio--1.5091.235+22%0.780+93%0.693+118%5.534-73%
Dividend Per Share---0.003-100%0.002-100%0.021-100%0.013-100%
Eps---0.312-0.335+7%-0.668+114%-0.429+37%-0.364+16%
Free Cash Flow Per Share--0.462-0.219+147%-0.529+214%-0.287+162%-0.240+152%
Free Cash Flow To Equity Per Share--0.450-0.369+182%-0.536+219%0.069+556%0.037+1122%
Gross Profit Margin--1.0001.052-5%1.151-13%1.041-4%1.039-4%
Intrinsic Value_10Y_max--26.270--------
Intrinsic Value_10Y_min--21.279--------
Intrinsic Value_1Y_max---0.847--------
Intrinsic Value_1Y_min---0.834--------
Intrinsic Value_3Y_max--0.107--------
Intrinsic Value_3Y_min--0.048--------
Intrinsic Value_5Y_max--4.258--------
Intrinsic Value_5Y_min--3.724--------
Market Cap23785404.000-49%35493819.10043025213.288-18%81352976.000-56%155005927.858-77%96878704.911-63%
Net Profit Margin---0.405-0.476+18%-0.969+139%-0.542+34%-0.719+77%
Operating Margin---0.374-0.458+23%-0.895+139%-0.484+30%-0.549+47%
Operating Ratio--1.3741.446-5%1.895-27%1.489-8%1.557-12%
Pb Ratio1.085-44%1.5641.478+6%1.291+21%2.682-42%1.676-7%
Pe Ratio-1.104+31%-1.592-1.877+18%-1.847+16%-7.199+352%-4.499+183%
Price Per Share1.380-44%1.9902.435-18%4.720-58%8.981-78%5.613-65%
Price To Free Cash Flow Ratio0.747-44%1.076-1.218+213%-2.175+302%-9.666+998%-6.042+661%
Price To Total Gains Ratio-4.890+31%-7.052-8.646+23%-8.250+17%-19.338+174%-19.338+174%
Quick Ratio--3.6175.073-29%7.892-54%8.924-59%5.722-37%
Return On Assets---0.098-0.092-6%-0.102+4%-0.072-27%-0.135+38%
Return On Equity---0.246-0.208-15%-0.185-25%-0.117-52%-0.751+206%
Total Gains Per Share---0.282-0.295+5%-0.614+117%0.104-371%0.052-641%
Usd Book Value--22694000.00029509250.000-23%59745500.000-62%51424850.000-56%27131656.250-16%
Usd Book Value Change Per Share---0.282-0.298+6%-0.616+118%0.083-439%0.039-825%
Usd Book Value Per Share--1.2721.671-24%3.466-63%2.975-57%1.569-19%
Usd Dividend Per Share---0.003-100%0.002-100%0.021-100%0.013-100%
Usd Eps---0.312-0.335+7%-0.668+114%-0.429+37%-0.364+16%
Usd Free Cash Flow--8243000.000-3822500.000+146%-9115500.000+211%-4952200.000+160%-4146031.250+150%
Usd Free Cash Flow Per Share--0.462-0.219+147%-0.529+214%-0.287+162%-0.240+152%
Usd Free Cash Flow To Equity Per Share--0.450-0.369+182%-0.536+219%0.069+556%0.037+1122%
Usd Market Cap23785404.000-49%35493819.10043025213.288-18%81352976.000-56%155005927.858-77%96878704.911-63%
Usd Price Per Share1.380-44%1.9902.435-18%4.720-58%8.981-78%5.613-65%
Usd Profit---5573000.000-6077250.000+9%-10373500.000+86%-6068950.000+9%-5262531.250-6%
Usd Revenue--13765000.00013137000.000+5%11729750.000+17%11506400.000+20%9130531.250+51%
Usd Total Gains Per Share---0.282-0.295+5%-0.614+117%0.104-371%0.052-641%
 EOD+4 -4MRQTTM+18 -18YOY+19 -175Y+15 -2110Y+18 -18

4.2. Fundamental Score

Let's check the fundamental score of Exagen Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-1.104
Price to Book Ratio (EOD)Between0-11.085
Net Profit Margin (MRQ)Greater than0-0.405
Operating Margin (MRQ)Greater than0-0.374
Quick Ratio (MRQ)Greater than13.617
Current Ratio (MRQ)Greater than14.020
Debt to Asset Ratio (MRQ)Less than10.601
Debt to Equity Ratio (MRQ)Less than11.509
Return on Equity (MRQ)Greater than0.15-0.246
Return on Assets (MRQ)Greater than0.05-0.098
Total3/10 (30.0%)

4.3. Technical Score

Let's check the technical score of Exagen Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5036.351
Ma 20Greater thanMa 501.473
Ma 50Greater thanMa 1001.718
Ma 100Greater thanMa 2001.812
OpenGreater thanClose1.370
Total0/5 (0.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets56,944
Total Liabilities34,250
Total Stockholder Equity22,694
 As reported
Total Liabilities 34,250
Total Stockholder Equity+ 22,694
Total Assets = 56,944

Assets

Total Assets56,944
Total Current Assets47,841
Long-term Assets9,103
Total Current Assets
Cash And Cash Equivalents 36,493
Net Receivables 6,551
Inventory 2,871
Other Current Assets 1,926
Total Current Assets  (as reported)47,841
Total Current Assets  (calculated)47,841
+/-0
Long-term Assets
Property Plant Equipment 8,487
Long-term Assets Other 416
Long-term Assets  (as reported)9,103
Long-term Assets  (calculated)8,903
+/- 200

Liabilities & Shareholders' Equity

Total Current Liabilities11,902
Long-term Liabilities22,348
Total Stockholder Equity22,694
Total Current Liabilities
Short-term Debt 1,730
Short Long Term Debt 264
Accounts payable 3,131
Other Current Liabilities 7,041
Total Current Liabilities  (as reported)11,902
Total Current Liabilities  (calculated)12,166
+/- 264
Long-term Liabilities
Long term Debt 19,231
Capital Lease Obligations Min Short Term Debt2,496
Long-term Liabilities Other 357
Long-term Liabilities  (as reported)22,348
Long-term Liabilities  (calculated)22,084
+/- 264
Total Stockholder Equity
Common Stock17
Retained Earnings -279,216
Other Stockholders Equity 301,893
Total Stockholder Equity (as reported)22,694
Total Stockholder Equity (calculated)22,694
+/-0
Other
Capital Stock17
Cash and Short Term Investments 36,493
Common Stock Shares Outstanding 17,836
Liabilities and Stockholders Equity 56,944
Net Debt -12,772
Net Invested Capital 42,189
Net Working Capital 35,939
Property Plant and Equipment Gross 14,256
Short Long Term Debt Total 23,721



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-31
> Total Assets 
0
0
0
16,451
18,019
15,292
16,947
17,149
16,146
15,849
15,792
14,627
0
0
28,887
28,887
30,721
33,088
92,744
88,310
84,644
80,513
79,993
78,375
137,522
133,323
127,772
123,445
122,044
107,724
101,597
86,221
79,234
64,178
60,928
56,944
56,94460,92864,17879,23486,221101,597107,724122,044123,445127,772133,323137,52278,37579,99380,51384,64488,31092,74433,08830,72128,88728,8870014,62715,79215,84916,14617,14916,94715,29218,01916,451000
   > Total Current Assets 
2,745
0
0
8,027
9,709
6,405
7,642
5,079
4,027
3,653
3,634
3,866
0
0
21,312
21,312
22,584
24,931
85,752
81,250
77,575
73,463
72,555
70,517
129,369
124,528
118,381
112,734
103,636
89,039
82,060
72,611
65,716
51,271
48,908
47,841
47,84148,90851,27165,71672,61182,06089,039103,636112,734118,381124,528129,36970,51772,55573,46377,57581,25085,75224,93122,58421,31221,312003,8663,6343,6534,0275,0797,6426,4059,7098,027002,745
       Cash And Cash Equivalents 
-2,745
0
0
7,743
9,487
6,118
7,123
4,605
3,498
2,917
2,737
2,509
0
0
13,164
13,164
14,327
16,237
77,828
72,084
68,648
63,700
61,434
57,448
118,050
112,576
106,766
99,442
89,751
76,387
68,704
62,391
52,184
31,466
28,448
36,493
36,49328,44831,46652,18462,39168,70476,38789,75199,442106,766112,576118,05057,44861,43463,70068,64872,08477,82816,23714,32713,16413,164002,5092,7372,9173,4984,6057,1236,1189,4877,74300-2,745
       Short-term Investments 
5,490
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000000000000000005,490
       Net Receivables 
0
0
0
54
3
0
0
0
0
0
0
0
0
0
5,952
5,952
6,439
6,733
6,238
5,715
5,843
7,263
9,297
8,910
8,221
8,780
9,210
9,654
10,911
9,590
10,639
6,077
9,303
16,235
17,044
6,551
6,55117,04416,2359,3036,07710,6399,59010,9119,6549,2108,7808,2218,9109,2977,2635,8435,7156,2386,7336,4395,9525,952000000000354000
       Other Current Assets 
0
0
0
230
219
287
519
474
529
736
897
606
0
0
1,174
1,174
1,818
1,021
1,686
3,451
3,084
947
841
4,159
921
986
1,010
3,638
998
1,077
2,717
4,143
4,229
3,570
3,416
1,926
1,9263,4163,5704,2294,1432,7171,0779983,6381,0109869214,1598419473,0843,4511,6861,0211,8181,1741,17400606897736529474519287219230000
   > Long-term Assets 
0
0
0
8,424
7,678
8,887
9,305
12,070
12,119
12,196
12,158
10,761
0
0
0
7,575
6,965
8,157
6,992
7,060
7,069
7,050
7,438
7,858
8,153
8,795
9,391
10,711
18,408
18,685
19,537
13,610
13,518
12,907
12,020
9,103
9,10312,02012,90713,51813,61019,53718,68518,40810,7119,3918,7958,1537,8587,4387,0507,0697,0606,9928,1576,9657,57500010,76112,15812,19612,11912,0709,3058,8877,6788,424000
       Property Plant Equipment 
0
0
0
1,228
1,201
1,502
1,593
1,538
1,430
1,327
1,409
1,594
0
0
1,566
1,566
1,459
1,239
1,314
1,380
1,376
1,370
1,758
2,102
2,378
3,054
3,446
4,772
12,201
12,554
13,445
13,082
12,915
12,287
11,382
8,487
8,48711,38212,28712,91513,08213,44512,55412,2014,7723,4463,0542,3782,1021,7581,3701,3761,3801,3141,2391,4591,5661,566001,5941,4091,3271,4301,5381,5931,5021,2011,228000
       Goodwill 
0
0
0
5,506
5,506
5,506
5,506
5,506
5,506
5,506
5,506
5,506
0
0
5,506
5,506
5,506
5,506
5,506
5,506
5,506
5,506
5,506
5,506
5,506
5,506
5,506
5,506
5,506
5,506
5,506
0
0
0
0
0
000005,5065,5065,5065,5065,5065,5065,5065,5065,5065,5065,5065,5065,5065,5065,5065,5065,506005,5065,5065,5065,5065,5065,5065,5065,5065,506000
       Intangible Assets 
0
0
0
1,025
971
918
870
805
752
698
560
514
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5,506
0
0
0
0
0
000005,5060000000000000000005145606987528058709189711,025000
       Other Assets 
0
0
0
0
632
0
0
0
0
0
0
0
0
0
503
503
1,172
1,412
172
174
187
174
174
250
269
235
439
433
701
625
586
528
603
0
0
0
0006035285866257014334392352692501741741871741721,4121,1725035030000000006320000
> Total Liabilities 
0
0
0
16,000
15,692
22,347
28,598
31,205
33,228
31,492
34,399
36,811
0
0
34,118
35,621
31,124
33,796
34,094
32,651
34,107
32,672
35,519
36,536
36,052
36,943
36,969
38,509
45,888
43,544
45,411
43,761
43,297
32,276
33,424
34,250
34,25033,42432,27643,29743,76145,41143,54445,88838,50936,96936,94336,05236,53635,51932,67234,10732,65134,09433,79631,12435,62134,1180036,81134,39931,49233,22831,20528,59822,34715,69216,000000
   > Total Current Liabilities 
0
0
0
10,579
15,692
16,990
22,378
26,261
28,459
28,809
32,462
34,917
0
0
8,952
8,952
5,624
6,721
7,662
5,895
7,329
5,755
8,274
8,771
7,884
8,265
8,096
9,318
11,884
9,573
11,332
9,623
9,268
8,603
10,119
11,902
11,90210,1198,6039,2689,62311,3329,57311,8849,3188,0968,2657,8848,7718,2745,7557,3295,8957,6626,7215,6248,9528,9520034,91732,46228,80928,45926,26122,37816,99015,69210,579000
       Short-term Debt 
0
0
0
8,915
0
14,324
18,204
18,517
20,081
18,602
21,449
25,903
0
0
0
81
0
152
179
238
241
242
272
308
394
547
586
587
1,541
1,658
1,009
1,230
1,326
1,361
1,399
1,730
1,7301,3991,3611,3261,2301,0091,6581,54158758654739430827224224123817915208100025,90321,44918,60220,08118,51718,20414,32408,915000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
190
254
257
261
264
2642612572541900000000000000000000000000000000
       Accounts payable 
0
0
0
726
913
1,358
2,352
1,839
2,183
1,354
957
2,182
0
0
1,279
1,279
1,139
1,494
1,213
1,476
2,566
1,438
2,454
3,014
2,170
2,450
1,512
2,492
4,214
3,105
3,669
3,046
1,878
1,309
1,657
3,131
3,1311,6571,3091,8783,0463,6693,1054,2142,4921,5122,4502,1703,0142,4541,4382,5661,4761,2131,4941,1391,2791,279002,1829571,3542,1831,8392,3521,358913726000
       Other Current Liabilities 
0
0
0
938
14,779
1,308
600
759
742
2,588
3,232
2,615
0
0
4,105
3,750
4,485
5,075
6,270
4,181
4,522
4,075
5,548
5,449
5,320
5,268
5,998
6,239
6,129
4,810
6,654
5,347
6,064
254
7,063
7,041
7,0417,0632546,0645,3476,6544,8106,1296,2395,9985,2685,3205,4495,5484,0754,5224,1816,2705,0754,4853,7504,105002,6153,2322,5887427596001,30814,779938000
   > Long-term Liabilities 
0
0
0
5,421
0
5,357
6,220
4,944
4,769
2,683
1,937
1,894
0
0
0
26,669
24,977
27,075
26,432
26,756
26,778
26,917
27,245
27,765
28,168
28,678
28,873
29,191
34,004
33,971
34,079
34,138
34,029
23,673
23,305
22,348
22,34823,30523,67334,02934,13834,07933,97134,00429,19128,87328,67828,16827,76527,24526,91726,77826,75626,43227,07524,97726,6690001,8941,9372,6834,7694,9446,2205,35705,421000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
25,331
25,677
25,854
26,050
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000026,05025,85425,67725,33100000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
270
270
258
258
245
266
147
147
147
530
1,304
1,605
1,585
1,713
325
1,116
331
19
0
0
0
0
0000193311,1163251,7131,5851,6051,30453014714714726624525825827027000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
400
400
1,200
1,200
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000001,2001,20040040000000000000000
> Total Stockholder Equity
4,822
0
0
451
-2,090
-7,055
-11,651
-14,056
-17,082
-15,643
-18,607
-22,184
0
0
-111,966
-6,734
-403
-708
58,650
55,659
50,537
47,841
44,474
41,839
101,470
96,380
90,803
84,936
76,156
64,180
56,186
42,460
35,937
31,902
27,504
22,694
22,69427,50431,90235,93742,46056,18664,18076,15684,93690,80396,380101,47041,83944,47447,84150,53755,65958,650-708-403-6,734-111,96600-22,184-18,607-15,643-17,082-14,056-11,651-7,055-2,090451004,822
   Retained Earnings -279,216-273,643-268,228-263,215-255,527-241,174-231,721-218,412-208,140-201,087-193,908-187,498-181,289-177,836-173,528-170,165-164,602-161,194-158,053-156,445-152,564-152,56400-108,452-105,919-102,413-92,727-89,269-86,660-81,847-77,857-74,288000
   Accumulated Other Comprehensive Income 0000000000000-2,787-2,648-2,521-2,395-2,284-2,1670-1,819000-2,176-2,051-1,851-1,657-1,628-1,529-1,4400-1,289000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
36,307
219,831
220,248
220,689
0
0
0
288,951
290,272
291,874
293,060
294,552
295,885
0
0
299,135
300,113
0
0
00300,113299,13500295,885294,552293,060291,874290,272288,951000220,689220,248219,83136,30700000000000000000
   Treasury Stock000000000000000000000000000000000000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue52,548
Cost of Revenue-23,092
Gross Profit29,45629,456
 
Operating Income (+$)
Gross Profit29,456
Operating Expense-52,293
Operating Income-22,837-22,837
 
Operating Expense (+$)
Research Development4,865
Selling General Administrative48,024
Selling And Marketing Expenses0
Operating Expense52,29352,889
 
Net Interest Income (+$)
Interest Income1,516
Interest Expense-2,335
Other Finance Cost-746
Net Interest Income-1,565
 
Pretax Income (+$)
Operating Income-22,837
Net Interest Income-1,565
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-23,656-22,018
EBIT - interestExpense = -25,172
-23,656
-21,354
Interest Expense2,335
Earnings Before Interest and Taxes (EBIT)-22,837-21,321
Earnings Before Interest and Taxes (EBITDA)-20,669
 
After tax Income (+$)
Income Before Tax-23,656
Tax Provision-33
Net Income From Continuing Ops-32,470-23,689
Net Income-23,689
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses75,385
Total Other Income/Expenses Net-8191,565
 

Technical Analysis of Exagen
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Exagen. The general trend of Exagen is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Exagen's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Exagen Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 1.41 < 1.42 < 1.42.

The bearish price targets are: 1.33 > 1.3003.

Tweet this
Exagen Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Exagen Inc. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Exagen Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Exagen Inc. The current macd is -0.08702912.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Exagen price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Exagen. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Exagen price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Exagen Inc Daily Moving Average Convergence/Divergence (MACD) ChartExagen Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Exagen Inc. The current adx is 24.68.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -2/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Exagen shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bearish trend could be forming. -1
Exagen Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Exagen Inc. The current sar is 1.48636153.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Exagen Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Exagen Inc. The current rsi is 36.35. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
Exagen Inc Daily Relative Strength Index (RSI) ChartExagen Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Exagen Inc. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -4/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Exagen price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Exagen Inc Daily Stochastic Oscillator ChartExagen Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Exagen Inc. The current cci is -100.67917829.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Exagen Inc Daily Commodity Channel Index (CCI) ChartExagen Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Exagen Inc. The current cmo is -31.51528863.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Exagen Inc Daily Chande Momentum Oscillator (CMO) ChartExagen Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Exagen Inc. The current willr is -67.16110424.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Exagen is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Exagen Inc Daily Williams %R ChartExagen Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Exagen Inc.

Exagen Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Exagen Inc. The current atr is 0.10918005.

Exagen Inc Daily Average True Range (ATR) ChartExagen Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Exagen Inc. The current obv is -46,924.

Exagen Inc Daily On-Balance Volume (OBV) ChartExagen Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Exagen Inc. The current mfi is 37.77.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Exagen Inc Daily Money Flow Index (MFI) ChartExagen Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Exagen Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-01MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-04STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-05CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-07CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-08SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-12-11STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-12STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-13MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-12-14STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-15STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-20MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2023-12-27SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-10STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-01-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-12STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-16STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-17CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-18RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-24SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-31STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-09CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-21SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-26DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-27DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-02-28DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-02-29DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-01STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-04DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-07STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-08CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-11WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-12SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-15BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-19STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-21STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-22STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-25BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-01STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-02WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-03STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-04MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-12SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-04-15SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-24STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

Exagen Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Exagen Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5036.351
Ma 20Greater thanMa 501.473
Ma 50Greater thanMa 1001.718
Ma 100Greater thanMa 2001.812
OpenGreater thanClose1.370
Total0/5 (0.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Exagen with someone you think should read this too:
  • Are you bullish or bearish on Exagen? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Exagen? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Exagen Inc

I send you an email if I find something interesting about Exagen Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Exagen Inc.

Receive notifications about Exagen Inc in your mailbox!